These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 34037665)

  • 1. Limited-Variant Screening vs Comprehensive Genetic Testing for Familial Hypercholesterolemia Diagnosis.
    Sturm AC; Truty R; Callis TE; Aguilar S; Esplin ED; Garcia S; Haverfield EV; Morales A; Nussbaum RL; Rojahn S; Vatta M; Rader DJ
    JAMA Cardiol; 2021 Aug; 6(8):902-909. PubMed ID: 34037665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cascade Screening for Familial Hypercholesterolemia in South Africa: The Wits FIND-FH Program.
    Raal FJ; Bahassi EM; Stevens B; Turner TA; Stein EA
    Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2747-2755. PubMed ID: 32878475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel LDLR disease-causing variant using capture-based next-generation sequencing screening of familial hypercholesterolemia patients in Taiwan.
    Hsiung YC; Lin PC; Chen CS; Tung YC; Yang WS; Chen PL; Su TC
    Atherosclerosis; 2018 Oct; 277():440-447. PubMed ID: 30270083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding the genetic spectrum for Chinese familial hypercholesterolemia population with six genetic mutations identified using a next-generation sequencing-based laboratory-developed screening test.
    Jingxin S; Shitong C
    Mol Genet Genomic Med; 2022 Dec; 10(12):e2070. PubMed ID: 36226792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-generation-sequencing-based identification of familial hypercholesterolemia-related mutations in subjects with increased LDL-C levels in a latvian population.
    Radovica-Spalvina I; Latkovskis G; Silamikelis I; Fridmanis D; Elbere I; Ventins K; Ozola G; Erglis A; Klovins J
    BMC Med Genet; 2015 Sep; 16():86. PubMed ID: 26415676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel low-density lipoprotein receptor variant in a Ukrainian patient: a case report and overview of the disease-causing low-density lipoprotein receptor variants associated to familial hypercholesterolemia.
    Moffa S; Onori ME; De Paolis E; Ricciardi Tenore C; Perrucci A; Pontecorvi A; Giaccari A; Urbani A; Minucci A
    Mol Biol Rep; 2022 Feb; 49(2):1623-1630. PubMed ID: 34846648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial Hypercholesterolemia Variant and Cardiovascular Risk in Individuals With Elevated Cholesterol.
    Zhang Y; Dron JS; Bellows BK; Khera AV; Liu J; Balte PP; Oelsner EC; Amr SS; Lebo MS; Nagy A; Peloso GM; Natarajan P; Rotter JI; Willer C; Boerwinkle E; Ballantyne CM; Lutsey PL; Fornage M; Lloyd-Jones DM; Hou L; Psaty BM; Bis JC; Floyd JS; Vasan RS; Heard-Costa NL; Carson AP; Hall ME; Rich SS; Guo X; Kazi DS; de Ferranti SD; Moran AE
    JAMA Cardiol; 2024 Mar; 9(3):263-271. PubMed ID: 38294787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel combined variants of LDLR and LDLRAP1 genes causing severe familial hypercholesterolemia.
    Alnouri F; Athar M; Al-Allaf FA; Abduljaleel Z; Taher MM; Bouazzaoui A; Al Ammari D; Karrar H; Albabtain M
    Atherosclerosis; 2018 Oct; 277():425-433. PubMed ID: 30270081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular screening of familial hypercholesterolemia in Icelanders.
    Kellogg G; Thorsson B; Cai Y; Wisotzkey R; Pollock A; Akana M; Fox R; Jansen M; Gudmundsson EF; Patel B; Chang C; Jaremko M; Puig O; Gudnason V; Emilsson V
    Scand J Clin Lab Invest; 2020 Oct; 80(6):508-514. PubMed ID: 32706999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Outcomes of Concurrent DNA and RNA Sequencing in Individuals Undergoing Hereditary Cancer Testing.
    Horton C; Hoang L; Zimmermann H; Young C; Grzybowski J; Durda K; Vuong H; Burks D; Cass A; LaDuca H; Richardson ME; Harrison S; Chao EC; Karam R
    JAMA Oncol; 2024 Feb; 10(2):212-219. PubMed ID: 37924330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeled Fetal Risk of Genetic Diseases Identified by Expanded Carrier Screening.
    Haque IS; Lazarin GA; Kang HP; Evans EA; Goldberg JD; Wapner RJ
    JAMA; 2016 Aug; 316(7):734-42. PubMed ID: 27533158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xanthomas Can Be Misdiagnosed and Mistreated in Homozygous Familial Hypercholesterolemia Patients: A Call for Increased Awareness Among Dermatologists and Health Care Practitioners.
    Alnouri F; Al-Allaf FA; Athar M; Abduljaleel Z; Alabdullah M; Alammari D; Alanazi M; Alkaf F; Allehyani A; Alotaiby MA; Alshehri A; Bouazzaoui A; Karrar H; Taher MM
    Glob Heart; 2020 Feb; 15(1):19. PubMed ID: 32489792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic spectrum of familial hypercholesterolemia and correlations with clinical expression: Implications for diagnosis improvement.
    Di Taranto MD; Giacobbe C; Palma D; Iannuzzo G; Gentile M; Calcaterra I; Guardamagna O; Auricchio R; Di Minno MND; Fortunato G
    Clin Genet; 2021 Nov; 100(5):529-541. PubMed ID: 34297352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refinement of pathogenicity classification of variants associated with familial hypercholesterolemia: Implications for clinical diagnosis.
    Di Costanzo A; Minicocci I; D'Erasmo L; Commodari D; Covino S; Bini S; Ghadiri A; Ceci F; Maranghi M; Catapano AL; Gazzotti M; Casula M; Montali A; Arca M
    J Clin Lipidol; 2021; 15(6):822-831. PubMed ID: 34756585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted genetic testing for familial hypercholesterolaemia using next generation sequencing: a population-based study.
    Norsworthy PJ; Vandrovcova J; Thomas ER; Campbell A; Kerr SM; Biggs J; Game L; Soutar AK; Smith BH; Dominiczak AF; Porteous DJ; Morris AD; Scotland G; Aitman TJ
    BMC Med Genet; 2014 Jun; 15():70. PubMed ID: 24956927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intronic variant screening with targeted next-generation sequencing reveals first pseudoexon in LDLR in familial hypercholesterolemia.
    Reeskamp LF; Balvers M; Peter J; van de Kerkhof L; Klaaijsen LN; Motazacker MM; Grefhorst A; van Riel NAW; Hovingh GK; Defesche JC; Zuurbier L
    Atherosclerosis; 2021 Mar; 321():14-20. PubMed ID: 33601267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimated Yield of Screening for Heterozygous Familial Hypercholesterolemia With and Without Genetic Testing in US Adults.
    Bellows BK; Khera AV; Zhang Y; Ruiz-Negrón N; Stoddard HM; Wong JB; Kazi DS; de Ferranti SD; Moran AE
    J Am Heart Assoc; 2022 Jun; 11(11):e025192. PubMed ID: 35583136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review.
    Groselj U; Kovac J; Sustar U; Mlinaric M; Fras Z; Podkrajsek KT; Battelino T
    Atherosclerosis; 2018 Oct; 277():383-391. PubMed ID: 30270075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Present and the Future of Genetic Testing in Familial Hypercholesterolemia: Opportunities and Caveats.
    Hooper AJ; Burnett JR; Bell DA; Watts GF
    Curr Atheroscler Rep; 2018 May; 20(6):31. PubMed ID: 29779130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of FH-Causing Variants and Impact on LDL-C Concentration in European, South Asian, and African Ancestry Groups of the UK Biobank-Brief Report.
    Gratton J; Humphries SE; Futema M
    Arterioscler Thromb Vasc Biol; 2023 Sep; 43(9):1737-1742. PubMed ID: 37409534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.